Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Health & MedicineOne-Off1y
Manifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastNo 79.4%
Forecasters
3
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 14 hours ago
StaleFeb 21, 23, 8:25 PM UTCDec 31, 27, 10:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRules
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
